Metoprolol Succinate
Product Images NDC 70882-126

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 70882-126). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cambridge Therapeutics Technologies, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Metoprolol Succinate Er Drl 1)

Chemical structure diagram of metoprolol succinate, showing the molecular components and arrangement of the active ingredient in the medication Metoprolol succinate by Cambridge Therapeutics Technologies, LLC.*

FDA Label Image

Figure (Metoprolol Succinate Er Drl 2)

A forest plot chart titled 'Results for Subgroups in MERIT-HF' showing relative risk and 95% confidence intervals for total mortality, total mortality or all-cause hospitalization, and total mortality or hospitalization for heart failure. The data compares metoprolol succinate extended-release tablets to placebo across multiple subgroups, including geographic location, NYHA classification, ejection fraction, etiology, sex, race, myocardial infarction history, diabetes, hypertension, and heart rate categories.*

FDA Label Image

Metoprolol Succinate Er Tablets 25 mg (Metoprolol Succinate Er Drl 3)

Packaging label for Metoprolol Succinate Extended-Release Tablets, USP 25 mg, containing 30 tablets. The label shows the product name, strength, tablet images, and instructions for a child-resistant lock-release feature. It is labeled Rx only and distributed by Cambridge Therapeutic Technologies, LLC. The label includes storage instructions and tamper-evident warnings, along with manufacturer and packager details.*

FDA Label Image

Metoprolol Succinate Er Tablets 50 mg (Metoprolol Succinate Er Drl 4)

Metoprolol succinate 50 mg extended-release tablets carton, labeler Cambridge Therapeutics Technologies, LLC. The packaging is predominantly white with purple accents and includes child-resistant lock release instructions with images. The carton holds 30 tablets and includes manufacturer information for Dr. Reddy's Laboratories Limited. The label features the NDC number 70882-127-30 and barcodes on the sides.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.